Clopidogrel plus aspirin for stroke prevention - Response

被引：0
|
作者：
Albers, GW [1 ]
Amarenco, P
机构：
[1] Stanford Univ, Sch Med, Stanford Stroke Ctr, Palo Alto, CA 94304 USA
[2] Hop Xavier Bichat, Paris, France
来源：
STROKE | 2002年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2547 / 2547
页数：1
相关论文
共 50 条
  • [1] Clopidogrel plus aspirin for stroke prevention
    Alberts, MJ
    Easton, JD
    STROKE, 2002, 33 (11) : 2546 - 2547
  • [2] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Thomson, Ruth M.
    Anderson, David C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (02)
  • [3] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Ruth M. Thomson
    David C. Anderson
    Current Neurology and Neuroscience Reports, 2013, 13
  • [4] Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis
    Blann, Andrew D.
    Skjoth, Flemming
    Rasmussen, Lars H.
    Larsen, Torben B.
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 403 - 409
  • [5] Aspirin plus plavix for stroke prevention
    中华物理医学与康复杂志, 2013, (08) : 633 - 633
  • [6] Dipyridamole plus aspirin for stroke prevention
    Easton, J. Donald
    LANCET NEUROLOGY, 2006, 5 (07): : 553 - 554
  • [7] Comparison between Aspirin and Clopidogrel for Secondary Stroke Prevention
    Chi, N. F.
    Hu, C. J.
    Hsu, C. Y.
    CEREBROVASCULAR DISEASES, 2016, 42 : 119 - 119
  • [8] Ticlopidine or clopidogrel as alternatives to aspirin in prevention of ischemic stroke
    Bendixen, BH
    Adams, HP
    EUROPEAN NEUROLOGY, 1996, 36 (05) : 256 - 257
  • [9] Stroke and the statistics of the aspirin/clopidogrel secondary prevention trials
    Howard, George
    McClure, Leslie A.
    Krakauer, John W.
    Coffey, Christopher S.
    CURRENT OPINION IN NEUROLOGY, 2007, 20 (01) : 71 - 77
  • [10] Combination aspirin and clopidogrel for secondary prevention of ischemic stroke
    Field T.S.
    Nakajima M.
    Benavente O.R.
    Current Treatment Options in Cardiovascular Medicine, 2013, 15 (3) : 348 - 359
12345